Cancer News and Research

Latest Cancer News and Research

Researchers identify MANF as a rejuvenating factor in parabiosis

Older mice who are surgically joined with young mice in order to share a common bloodstream get stronger and healthier, making parabiosis one of the hottest topics in age research. Publishing in Nature Metabolism, researchers from the Buck Institute report that MANF (mesencephalic astrocyte-derived neurotrophic factor) is one of the factors responsible for rejuvenating the transfused older mice.

16 Jan 2019

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKET™ immunotherapy drug candidates to patients in clinical trials beginning in 2019.

16 Jan 2019

Study: Induced neuronal cells derived from fibroblasts are similar to neurons in the brain

The incidence of some neurological diseases--especially those related to aging, such as Alzheimer's and Parkinson's diseases--is increasing

16 Jan 2019

FDA-approved drug hampers cancer metastasis in animal model, shows study

For cancer to spread, it needs a hospitable environment in distant organs. This fertile "soil" can provide a home to circulating malignant cells.

16 Jan 2019

New evidence shows how fever alters immune cells

Fever is known to help power up our immune cells, and scientists in Shanghai have new evidence explaining how.

16 Jan 2019

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.

16 Jan 2019

Educational videos in clinical settings increase HPV vaccination rates among adolescents

A study examining the effect of a video educational intervention aimed at increasing HPV vaccinations among adolescents could help the Centers for Disease Control and Prevention meet its goal of getting more eligible adolescents vaccinated against certain cancers and diseases caused by the human papillomavirus (HPV).

16 Jan 2019

Study points to potential new biomarker and drug target for amyotrophic lateral sclerosis

Research led by stem cell scientists at Harvard University points to a potential new biomarker and drug target for amyotrophic lateral sclerosis, a neurological disease that is extremely difficult to diagnose and treat.

16 Jan 2019

Study: States with lower incidence of melanoma have higher mortality rates

Skin cancer is the most common cancer in the United States. While the number of cases diagnosed is on the rise, the overall survival rate has improved, but survival is uneven across the country.

15 Jan 2019

New, scalpel-free treatment for reducing Parkinson's tremor gets FDA approval

The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease.

15 Jan 2019

Researchers identify a key regulator that stops excessive inflammation

A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.

15 Jan 2019

One time use of Marijuana could affect teen brains finds study

A survey from 2018 had found that 2.1 million students from middle and high schools have smoked marijuana at least once. A new study looked at the effects of marijuana or cannabis on the brains of adolescents.

15 Jan 2019

Researchers discover how cancer cells avoid genetic meltdown

A team of scientists have shed light on how cancer cell populations avoid genetic meltdown, despite the rapid accumulation of harmful mutations.

15 Jan 2019

Scientists create comprehensive new method to predict breast cancer risk

Scientists have created the most comprehensive method yet to predict a woman's risk of breast cancer, according to a study by Cancer Research UK published in Genetics in Medicine.

14 Jan 2019

Synthetic compound reverses mutant p53 aggregate accumulation, study shows

Cancer is a multidisciplinary disease, with different mutations leading to different prognoses and treatment necessities. Among the most important mutation targets in cancers, affecting more than 50% of all cancer cases, is TP53.

14 Jan 2019

Study shows how herpes viruses and tumors have learned to manipulate the same ancient RNA

Herpes viral infections use the ancient genetic material found in the human genome to proliferate, mimicking the same process tumors have been found to manipulate, Mount Sinai researchers have shown for the first time.

14 Jan 2019

Virtual video visits can replace office visits without compromising quality of care

A team of researchers at Massachusetts General Hospital (MGH) reports in the American Journal of Managed Care that virtual video visits, one form of telehealth visit used at the hospital, can successfully replace office visits for many patients without compromising the quality of care and communication.

14 Jan 2019

Scientists identify endogenous activator of sigma-1 receptors in human cells

Cells communicate through complex mechanisms that typically involve receptors and ligands that bind to them. Endogenous ligands, produced by the body, have been identified for the vast majority of cellular receptors, helping explain receptor existence and function. But in the case of sigma-1 receptors, which interact with a diverse array of psychoactive drugs, an endogenous ligand has remained elusive.

14 Jan 2019

Researchers identify multiple new subtypes of most common childhood cancer

Like cartographers completing a map, investigators have identified multiple new subtypes of the most common childhood cancer--research that will likely improve the diagnosis and treatment of high-risk patients.

14 Jan 2019

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Unlike healthy tissues, tumors thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despite being a well-known cause of therapy resistance and metastasis, the impact of low oxygen, known as hypoxia, on tumor cells is poorly understood.

14 Jan 2019

Cancer News and Research

Latest Cancer News and Research

Researchers identify MANF as a rejuvenating factor in parabiosis

MD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

Study: Induced neuronal cells derived from fibroblasts are similar to neurons in the brain

FDA-approved drug hampers cancer metastasis in animal model, shows study

New evidence shows how fever alters immune cells

Researchers find how GREB1 gene promotes resistance to prostate cancer treatments

Educational videos in clinical settings increase HPV vaccination rates among adolescents

Study points to potential new biomarker and drug target for amyotrophic lateral sclerosis

Study: States with lower incidence of melanoma have higher mortality rates

New, scalpel-free treatment for reducing Parkinson's tremor gets FDA approval

Researchers identify a key regulator that stops excessive inflammation

One time use of Marijuana could affect teen brains finds study

Researchers discover how cancer cells avoid genetic meltdown

Scientists create comprehensive new method to predict breast cancer risk

Synthetic compound reverses mutant p53 aggregate accumulation, study shows

Study shows how herpes viruses and tumors have learned to manipulate the same ancient RNA

Virtual video visits can replace office visits without compromising quality of care

Scientists identify endogenous activator of sigma-1 receptors in human cells

Researchers identify multiple new subtypes of most common childhood cancer

Molecular hallmarks of tumor hypoxia across 19 cancer types discovered

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in